Forma Therapeutics (FMTX) PT Lowered to $54 at SVB Leerink, Following Clinical Business Update
Tweet
Share
E-mailGet Alerts FMTX Hot Sheet
Price: $20.01 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
SVB Leerink analyst Andrew Berens lowered the price target on Forma Therapeutics (NASDAQ: FMTX) to $54.00 (from $65.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
- Veeva Systems (VEEV) PT Raised to $275 at Stifel on Expected Q2 Outperformance
- Gemini Space Station (GEMI) PT Lowered to $6 at Rosenblatt
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Andrew BerensSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
